Cargando…
Pharmacological Melanocortin 5 Receptor Activation Attenuates Glomerular Injury and Proteinuria in Rats With Puromycin Aminonucleoside Nephrosis
Clinical evidence indicates that the melanocortin peptide ACTH is effective in inducing remission of nephrotic glomerulopathies like minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS), including those resistant to steroids. This suggests that a steroid-independent melancortin...
Autores principales: | Chen, Bohan, Alam, Zubia, Ge, Yan, Dworkin, Lance, Gong, Rujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198460/ https://www.ncbi.nlm.nih.gov/pubmed/35721571 http://dx.doi.org/10.3389/fphys.2022.887641 |
Ejemplares similares
-
Association of Proteinuria with Urinary Concentration Defect in Puromycin Aminonucleoside Nephrosis
por: Jo, Chor Ho, et al.
Publicado: (2020) -
Effects of Celecoxib and Nordihydroguaiaretic Acid on Puromycin Aminonucleoside-Induced Nephrosis in the Rat
por: Lee, Dong Won, et al.
Publicado: (2009) -
Effects of Dietary Salt Restriction on Puromycin Aminonucleoside Nephrosis: Preliminary Data
por: Jo, Chor Ho, et al.
Publicado: (2011) -
Impact of Cyclosporin on Podocyte ZO-1 Expression in Puromycin Aminonucleoside Nephrosis Rats
por: Kim, Beom Seok, et al.
Publicado: (2005) -
Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis rats
por: Kawamorita, Yosuke, et al.
Publicado: (2017)